Axe Compute Inc Quick Ratio (AGPU) starting from the first quarter 2026 to first quarter 2013, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Axe Compute Inc  (NASDAQ: AGPU)

Axe Compute Inc's Quick Ratio

AGPU's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2026, Quick Ratio deteriorated to 1.64 above company average Quick Ratio.

Within Medical Equipment & Supplies industry 59 other companies have achieved higher Quick Ratio than Axe Compute Inc in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 0 to 1009.

Explain Quick Ratio?
How much Cash & cash equivalents AGPU´s has?
What are AGPU´s Current Liabilities?




AGPU Quick Ratio (Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Jun 30 2014)
(Mar 31 2014)
(Dec 31 2013)
Y / Y Current Liabilities Change 21.86 % 208.03 % 40.08 % -2.6 % 1.6 %
Y / Y Cash & cash equivalent Change 6692.58 % 3186.27 % -70.71 % -64.94 % 675.96 %
Quick Ratio MRQ 1.64 2.53 0.01 0.06 0.03
AGPU's Total Ranking # 1009 # 0 # # #
Seq. Current Liabilities Change -0.93 % 9.24 % 66.36 % -32.32 % 150.44 %
Seq. Cash & cash equivalent Change -35.82 % 26775.67 % -69.29 % 28.23 % -68.95 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 60
Healthcare Sector # 425
Overall Market # 1009


Quick Ratio Statistics
High Average Low
2.53 0.37 0
(Dec 31 2025)   (Dec 31 2012)




Financial Statements
Axe Compute Inc's Current Liabilities $ 4 Millions Visit AGPU's Balance sheet
Axe Compute Inc's Cash & cash equivalent $ 7 Millions Visit AGPU's Balance sheet
Source of AGPU's Sales Visit AGPU's Sales by Geography


Cumulative Axe Compute Inc's Quick Ratio

AGPU's Quick Ratio for the trailling 12 Months

AGPU Quick Ratio

(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Jun 30 2014)
12 Months
(Mar 31 2014)
12 Months
(Dec 31 2013)
12 Months
Y / Y Current Liabilities TTM Growth 46.7 % 39.92 % -0.01 % -7.22 % -8.1 %
Y / Y Cash & cash equivalent TTM Growth 1802.39 % 1199.44 % -3.84 % 33.38 % 443.64 %
Quick Ratio TTM 1.21 0.79 0.05 0.07 0.09
Total Ranking TTM # # # # #
Seq. Current Liabilities TTM Growth 5.42 % 25.94 % 11.19 % -0.62 % 0.55 %
Seq. Cash & cash equivalent TTM Growth 61.67 % 1740.26 % -13.88 % -25.75 % 10.43 %


On the trailing twelve months basis AGPU Cash & cash equivalent more than doubled by 6692.58 % in Q1 2026 year on year, faster than Current Liabilities, this led to increase in in Axe Compute Inc's Quick Ratio to 1.21, above AGPU average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 59 other companies have achieved higher Quick Ratio than Axe Compute Inc. While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents AGPU´s has?
What are AGPU´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 60
Healthcare Sector # 425
Within the Market # 1009


trailing twelve months Quick Ratio Statistics
High Average Low
2.53 0.37 0
(Dec 31 2025)   (Dec 31 2012)




Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Medical Equipment & Supplies Industry Quick RatioMar 31 2026 MRQ Cash & cash equivalentMar 31 2026 MRQ Current Liabilities
Biolife Solutions Inc   4.44 $ 80.996  Millions$ 18.253  Millions
Soleno Therapeutics Inc  4.40 $ 255.599  Millions$ 58.049  Millions
Inspiremd Inc   4.40 $ 41.570  Millions$ 9.443  Millions
Axogen inc   4.25 $ 101.601  Millions$ 23.898  Millions
Outset Medical Inc   4.17 $ 156.706  Millions$ 37.607  Millions
Innovative Eyewear Inc   4.14 $ 4.378  Millions$ 1.059  Millions
Autonomix Medical Inc   4.11 $ 7.004  Millions$ 1.705  Millions
Fractyl Health Inc   4.10 $ 63.168  Millions$ 15.408  Millions
Hyperfine Inc   4.02 $ 40.778  Millions$ 10.154  Millions
Orasure Technologies Inc  4.01 $ 176.964  Millions$ 44.084  Millions
Kestra Medical Technologies Ltd   3.90 $ 196.434  Millions$ 50.372  Millions
Procept Biorobotics Corporation  3.86 $ 245.641  Millions$ 63.636  Millions
Clearpoint Neuro Inc   3.75 $ 35.593  Millions$ 9.480  Millions
Mimedx Group Inc   3.59 $ 159.773  Millions$ 44.550  Millions
Aethlon Medical Inc   3.47 $ 5.026  Millions$ 1.447  Millions
Novocure Limited  3.40 $ 432.004  Millions$ 127.239  Millions
Nexalin Technology Inc   3.35 $ 2.708  Millions$ 0.808  Millions
Capsovision Inc   3.34 $ 17.933  Millions$ 5.363  Millions
Neuropace Inc   3.34 $ 53.981  Millions$ 16.168  Millions
Apyx Medical Corp  3.30 $ 31.137  Millions$ 9.447  Millions
Pulmonx Corporation  3.26 $ 61.572  Millions$ 18.906  Millions
Anika Therapeutics Inc   3.19 $ 66.788  Millions$ 20.966  Millions
Inspire Medical Systems inc   3.17 $ 283.834  Millions$ 89.418  Millions
Sensus Healthcare Inc   3.13 $ 18.327  Millions$ 5.859  Millions
Glaukos Corp  3.09 $ 276.685  Millions$ 89.415  Millions
Strata Critical Medical Inc   2.96 $ 59.053  Millions$ 19.955  Millions
Vivani Medical Inc   2.91 $ 19.749  Millions$ 6.775  Millions
Penumbra Inc  2.91 $ 615.660  Millions$ 211.731  Millions
Tandem Diabetes Care Inc   2.86 $ 570.256  Millions$ 199.075  Millions
Valion Bio Inc   2.76 $ 7.215  Millions$ 2.615  Millions

Date modified: 2026-08-29T17:22:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.